Peptide Database
Browse all 100 research peptides with detailed profiles, dosing information, and safety data.
Showing 11 of 100 peptides
CJC-1295
A synthetic Growth Hormone Releasing Hormone (GHRH) analog that stimulates pulsatile GH release. Available with or without DAC (Drug Affinity Complex) for different duration profiles.
CJC-1295 no DAC
CJC-1295 no DAC is a growth hormone-releasing hormone (GHRH) analog that stimulates natural growth hormone production. It provides similar benefits to CJC-1295 with DAC but with a shorter duration of action, requiring more frequent dosing.
CJC-1295 with DAC
CJC-1295 with Drug Affinity Complex (DAC) is a long-acting GHRH analog with an extended half-life of 6-8 days. The DAC modification allows for sustained GH elevation with less frequent dosing compared to non-DAC variants.
GHRP-2
A second-generation Growth Hormone Releasing Peptide offering potent GH release with moderate appetite stimulation. Considered a balanced option between GHRP-6's hunger effects and Ipamorelin's selectivity.
GHRP-6
A first-generation Growth Hormone Releasing Peptide known for its strong appetite stimulation and potent GH release. Popular for those seeking weight gain and muscle building.
Hexarelin
Hexarelin is a synthetic hexapeptide growth hormone secretagogue and one of the most potent GHRP-class peptides. It stimulates robust GH release via the ghrelin receptor while also exhibiting cardioprotective properties independent of GH signaling.
IGF-1 LR3
A synthetic, highly potent analog of IGF-1 with an extended half-life of 20-30 hours, capable of inducing muscle hyperplasia and systemic anabolic effects.
Ipamorelin
A selective third-generation Growth Hormone Releasing Peptide (GHRP) known as the 'cleanest' GHRP due to its pure GH release without affecting cortisol, prolactin, or hunger.
Pramorelin
Pramorelin is a synthetic growth hormone-releasing peptide (GHRP) analog that stimulates growth hormone release from the pituitary gland. Research suggests it may support increased growth hormone levels and related metabolic benefits, though human clinical data remains limited.
Sermorelin
The first synthetic GHRH analog, consisting of the first 29 amino acids of natural GHRH. Previously FDA-approved for pediatric growth hormone deficiency, now widely used in anti-aging medicine.
Tesamorelin
An FDA-approved GHRH analog specifically indicated for reducing visceral adiposity in HIV patients. Provides targeted fat loss while maintaining lean mass.